Ozempic and Mounjaro sit at different points on the incretin spectrum: one is a GLP-1-selective agonist, the other a dual GIP and GLP-1 agonist. This independent review compares their molecular design, FDA labels, trial programs, safety, monthly cost, and the shared genetics that sit beneath both compounds.

This independent comparison of Mounjaro and Ozempic covers how each engages the incretin system, where their FDA labels diverge, what the SURPASS and SUSTAIN trial programs measured, published list pricing as of April 2026, and the shared genetic pathways that sit above both molecules regardless of which is prescribed.

Zepbound and Wegovy were both brought to market specifically for chronic weight management, making this a direct obesity-treatment comparison. As of April 2026, this editorial piece contrasts their dual-versus-selective design, STEP and SURMOUNT evidence, list prices, and shared genetic terrain.

Wegovy and Zepbound are the two injectables FDA-approved specifically for chronic weight management, making this a rare like-for-like comparison. This independent review sets single-hormone semaglutide against dual-hormone tirzepatide on action, labels, evidence, safety, and cost, then the genetics both share as a common starting line.

Semaglutide dosing is best understood through the FDA label. This guide reports the label-level ranges and the titration concept, explains why the graduated schedule exists and why formulation matters, and deliberately leaves every individual dose decision to a qualified prescriber who knows your history.

Here is the catch most Wegovy-versus-Ozempic searches miss: both are the same molecule, semaglutide, sold under two brand names. This independent review explains where dose, indication, price, and coverage actually diverge, and why the underlying genetics stay identical no matter which label you fill.

Retatrutide has no FDA label and no approved dose because it is still investigational and in clinical trials. Any online dosing plan is unofficial and unsafe to follow. This article explains how approved dosing is set and what regulated GLP-1 options a provider can discuss.

The GLP-1 medication category has grown quickly and can be hard to keep straight. This roster explains what the hormone is, how the receptor-agonist class works, which compounds are FDA-approved as of April 2026, and the inherited variables that sit beneath the pathway.

Trulicity, or dulaglutide, has a defined FDA-label dosing structure. This guide reports the label dose range, the once-weekly single-dose pen format, and why a graduated titration exists — without prescribing direction. Dose decisions belong with a provider who knows your history, and this is context rather than instruction.

Ozempic and Wegovy share one molecule, semaglutide, but carry different FDA indications and doses. This independent review explains why the underlying pharmacology stays identical while the labels, trial programs, list price, and appetite genetics that shape each decision are what actually set them apart.

Interest in a semaglutide pill keeps growing. This guide explains which oral GLP-1 options are FDA-approved, how absorption technology makes a pill possible, how oral and injectable delivery differ, what drives cost, and the genetic context behind any semaglutide decision.

Microdose GLP-1 protocols use lower-than-standard doses of GLP-1 receptor agonists titrated by a clinician for better tolerability. This article covers what microdose means, the rationale, and the PlexusDx Microdose GLP-1 protocol inside the Weight Management Protocols collection.

Why a Mounjaro “coupon” rarely means a single discount code. This article explains the manufacturer savings card, third-party pharmacy discount platforms, and how compounded options change the math against the roughly $1,069 monthly list price, all as published in 2026.

This page reports Zepbound's FDA-label dosing facts: a 2.5 mg starting dose titrated to 5, 10, or 15 mg weekly, delivered as a once-weekly injection. It explains why titration is engineered in and adds the genetic context PlexusDx places upstream of any protocol.

This article reports the FDA-label facts behind Ozempic dosing, including the starting and maintenance range and once-weekly subcutaneous administration. It explains why titration is gradual, what tolerability topics belong with your provider, and why dose adjustments are never made on your own.

Zepbound's published list price is about $1,059 per month as of April 2026, but insurance, the prescribed indication, savings cards, and pharmacy coupons all reshape that figure. This overview explains each factor and the genetic context PlexusDx places upstream of any protocol.

A clear look at how Ozempic coupons work in 2026: the manufacturer savings card, third-party discount platforms, how insurance status changes their value, the list price behind the discount, and the compounded alternative pathway.

Coupons and savings programs are the most-searched way to soften Wegovy's monthly price. This article separates the manufacturer savings card from pharmacy discount coupons, explains why the drug is priced high, and outlines where compounded protocols and upstream genetic context fit into the decision.

A plain breakdown of Ozempic pricing in 2026: the published list price, why insured patients rarely pay it, manufacturer and pharmacy savings, compounded semaglutide and the shortage timeline, and how PlexusDx prices its GLP-1 protocols.

Ozempic Vulva explained — what is being described, why it can happen, what the published trial evidence shows, and the GLP-1 pathway genetic context. Treated with clinical dignity. Individual results vary.

GLP-1 drugs are engineered from a natural gut hormone that resists rapid breakdown. This article traces the biology, explains how the receptor agonist class works, lists the FDA-approved and investigational compounds as of April 2026, and covers the genetics sitting upstream.

There is no drug or hormone class called GLP-3 — searchers almost always mean GLP-1 receptor agonists. This PlexusDx disambiguation clears up the name, explains what the real class is, lists the approved products and formats, and points to the genetics beneath.

GLP-1 was a gut hormone long before it was a medication. This PlexusDx explainer defines glucagon-like peptide-1, follows its actions, explains why it was engineered into a drug class, lists the approved compounds, and turns to the GLP1R pathway underneath.

Searching for GLP-1 pills usually means wanting appetite and glucose support without a weekly shot. This guide covers the single FDA-approved oral option, why swallowing a peptide is difficult, the compounded and investigational landscape, and how the format you choose shapes both the routine and the cost.

Searching for a Wegovy pill leads somewhere unexpected: the injection has no tablet form. This guide explains the oral GLP-1 products that genuinely exist, why swallowing a peptide is difficult, how a pill compares with the weekly shot, and where your genetics fit.

Mounjaro (tirzepatide, Eli Lilly) is a GLP-1 receptor agonist with a well-characterized safety profile. This article covers common side effects, serious warnings, the boxed-warning context, and when to call a provider — plus the genetic variables that shape baseline GLP-1 biology.

Ozempic (semaglutide, Novo Nordisk) is a GLP-1 receptor agonist with a well-characterized safety profile. This article covers common side effects, serious warnings, the boxed-warning context, and when to call a provider — plus the genetic variables that shape baseline GLP-1 biology.

Wegovy (semaglutide, Novo Nordisk) is a GLP-1 receptor agonist with a well-characterized safety profile. This article covers common side effects, serious warnings, the boxed-warning context, and when to call a provider — plus the genetic variables that shape baseline GLP-1 biology.

Can you take a GLP-1 as a pill? This article covers what is approved in tablet form, why turning a peptide into an oral medicine is difficult, how a pill compares to a weekly injection, what an oral option costs, and the genetic context that applies under any format.

There is no Wegovy pill — Wegovy is injection-only. This page explains which oral GLP-1 options exist in April 2026, how an oral peptide manages to survive the stomach, how the pills compare with the weekly injection, and what the oral options actually cost.